ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings
  • Abstract Number: 704 • 2013 ACR/ARHP Annual Meeting

    Evaluating The Effects Of Combination Aspirin and Dipyridamole (asasantin retard) On Platelet Function, Oxidative Stress and Peripheral Vascular Function In Primary Raynaud’s Phenomenon and Systemic Sclerosis

    John D. Pauling1, Jacqueline A. Shipley1, Darren Hart1, Ginger L. Milne2 and Neil J McHugh1,3, 1Rheumatology, Royal National Hospital for Rheumatic Diseases, Bath, United Kingdom, 2Division of Clinical Pharmacology, Vanderbilt University School of Medicine, Nashville, TN, 3Department of Pharmacy and Pharmacology, University of Bath, Bath, United Kingdom

    Background/Purpose: There is evidence of enhanced platelet activation in Raynaud’s phenomenon (RP), particularly in systemic sclerosis (SSc). Upon activation, platelets release vasoconstrictive mediators (e.g. thromboxane…
  • Abstract Number: 705 • 2013 ACR/ARHP Annual Meeting

    Treatment With Rituximab Reduces Activation Of Scleroderma Dermal Fibroblasts

    Paolo Fraticelli1, Salvatore De Vita2, Nicoletta Franzolini3, Silvia Svegliati4, Cecilia Tonnini4, Barbara Gabrielli5, Cathryn Anne Scott6, Giovanni Pomponio7, Gianluca Moroncini4 and Armando Gabrielli4, 1Istituto di Clinica Medica, Università Politecnica delle Marche, Ancona, Italy, 2Rheumatology, DSMB, University Hospital Santa Maria della Misericordia, Udine, Italy, 3Presidio Ospedaliero di San Daniele del Friuli, ASS 4 “Medio Friuli, Udine, Italy, 4Scienze Cliniche e Molecolari, Università Politecnica delle Marche, Ancona, Italy, 5Università Politecnica delle Marche, Ancona, Italy, 6Department of Medical and Biological Sciences, Università degli studi di Udine ·, Udine, Italy, 7Medicina Interna, Ospedali Riuniti, Ancona, Italy

    Background/Purpose:  There is evidence that B lymphocytes play a role in the pathogenesis  of systemic sclerosis (scleroderma). Stimulatory autoantibodies targeting PDGF receptor and activating normal…
  • Abstract Number: 706 • 2013 ACR/ARHP Annual Meeting

    Effect Of Aminaftone On Raynaud’s Phenomenon Secondary To Systemic Sclerosis: A Double-Blind Prospective, Randomized, Placebo-Controlled Pilot Study

    Alessandro Santaniello1, Barbara Vigone2, Monica Caronni2 and Lorenzo Beretta3, 1Referral Center for Systemic Autoimmune Diseases, Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico di Milano, Milan, Italy, 2Referral Center for Systemic Autoimmune Diseases, Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, Milan, Italy, 3Referral Center for Systemic Autoimmune Diseases, Fondazione IRCCS Ca’ Granda Ospedale Maggiore Policlinico di Milano, Milan, Italy

    Background/Purpose: Raynaud’s phenomenon (RP) is a pivotal manifestation of systemic sclerosis (SSc) which reflects an underlying vasculopathy. Endothelial activation with increased circulating levels of Endothelin-1…
  • Abstract Number: 663 • 2013 ACR/ARHP Annual Meeting

    Propylthiouracil Attenuates Aortic Vasculopathy In An Animal Model Of Systemic Sclerosis

    Gianluca Bagnato1, Alessandra Bitto2, Gabriele Pizzino2, Neal Roberts3, Domenica Altavilla2, Francesco Squadrito2, Gianfilippo Bagnato1 and Antonino Saitta4, 1Rheumatology, University of Messina, Messina, Italy, 2Pharmacology, University of Messina, Messina, Italy, 3University of Louisville, Louisville, KY, 4Internal Medicine, University of Messina, Messina, Italy

    Background/Purpose: Systemic sclerosis (SSc) is a generalized connective tissue disorder of unknown etiology characterized by thickening and fibrosis of the skin and distinctive visceral involvement…
  • Abstract Number: 664 • 2013 ACR/ARHP Annual Meeting

    Formate, Acetate and Acetone : News Biomarkers in Systemic Sclerosis identified by Metabolomics

    Emmanuel Chatelus1, Francois Marie Moussallieh2, Christelle Sordet1, Arnaud Theulin1, Alain Meyer1, Karim El Bayed3, Jean Francois Kleinmann1, Jean Sibilia1, Jacques-Eric Gottenberg4 and Izzie Jacques Namer2, 1Rheumatology, Strasbourg University Hospital, Strasbourg, France, 2Nuclear Medicine, Strasbourg University Hospital, Strasbourg, France, 3UMR 7177 CNRS/Strasbourg University, Strasbourg, France, 4Strasbourg University Hospital, Strasbourg, France

    Background/Purpose: High throughput study of metabolic pathways might help identify new biomarkers and therapeutic targets in autoimmune diseases. Systemic sclerosis (SSc) currently lacks prognostic biomarkers…
  • Abstract Number: 665 • 2013 ACR/ARHP Annual Meeting

    DNA hypermethylation of Forkhead box protein 3 (FOXP3) locus leads to quantitative defects of regulatory T cells in systemic sclerosis

    Yaoyao Wang1, Ye Shu2, Qing Wang1, Ming Zhao1, Gongping Liang1, Qianjin Lu1 and Rong Xiao1, 1Department of Dermatology, Second Xiangya Hospital, Central South University, Changsha, China, 2Department of Dermatology, Hunan Children's Hospital, Changsha, China

    Background/Purpose: Systemic sclerosis (SSc) is a systemic autoimmune disease of which the etiology and pathogenesis remains complex and poorly understood.  Attention has recently been directed…
  • Abstract Number: 666 • 2013 ACR/ARHP Annual Meeting

    Involvement Of TCR Vdelta1+ NKT Cells In Systemic Sclerosis: Association With Interstitial Pneumonia

    Seiji Segawa1, Daisuke Goto2, Masanobu Horikoshi2, Yuya Kondo3, Naoto Umeda2, Shinya Hagiwara2, Masahiro Yokosawa4, Tomoya Hirota3, Haruka Miki1, Hiroto Tsuboi3, Hiroshi Ogishima2, Takeshi Suzuki4, Isao Matsumoto5 and Takayuki Sumida3, 1Department of Internal Medicine, Faculty of Medicine, University of Tsukuba, Ibaraki, Japan, 2Department of Internal Medicine, Faculty of Medicine, University of Tsukuba, Tsukuba City, Japan, 3Department of Internal Medicine, Faculty of Medicine, University of Tsukuba, Tsukuba, Japan, 4Department of Internal Medicine, Faculty of Medicine, University of Tsukuba, Tsukuba, Ibaraki, Japan, 5Department of Internal Medicine, Faculty of Medicine,, University of Tsukuba, Tsukuba, Japan

    Background/Purpose: Interstitial pneumonia (IP) is one of the critical complications in patients with several autoimmune diseases. However, the exact mechanism of IP remains elusive. Recently,…
  • Abstract Number: 667 • 2013 ACR/ARHP Annual Meeting

    IL6 and CCL2 Co-Regulate Fibroblast Dependent Trans-Endothelial Migration Of Mononuclear Cells and Fibrotic Response In Scleroderma

    Rebecca Alade1, Korsa Khan2, Xu Shiwen3, Christopher P. Denton4 and Voon Ong5, 1Centre for Rheumatology and Connective Tissue Diseases,, UCL Medical School, London, United Kingdom, 2Centre for Rheumatology and Connective Tissue Diseases, UCL medical School, London, United Kingdom, 3Rheumatology, Royal Free Hospital, London, United Kingdom, 4Centre for Rheumatology and Connective Tissue Diseases, UCL Medical School, London, United Kingdom, 5Department of Rheumatology, UCL Medical School, London, England

    Background/Purpose: IL6 is a key mediator recently implicated in activation of extracellular matrix (ECM) proteins in scleroderma (SSc) fibroblasts. CCL2 is a proinflammatory chemokine that…
  • Abstract Number: 668 • 2013 ACR/ARHP Annual Meeting

    Enhanced Expression Of The Cold-Sensing Receptor-TRPM8 In Scleroderma Endothelial Cells and Skin and Endothelial Dysfunction Following TRPM8 Activation

    Yongqing Wang1, David R. Giovannucci2 and Bashar Kahaleh3, 1Medicine, University of Toledo, Toledo, OH, 2Neurosciences, University of Toledo, Toledo, OH, 3Medicine/Rheumatology, University of Toledo, Toledo, OH

    Background/Purpose: Cold exposure induces vasospasm and incites reperfusion injury in SSc. The mechanisms responsible for enhanced cold sensitivity in SSc are poorly understood. Transient receptor…
  • Abstract Number: 669 • 2013 ACR/ARHP Annual Meeting

    Up-Regulated Expression Of CXCL5 In Circulating Platelets From Patients With Systemic Sclerosis: A Role In Fibrosis

    Hidekata Yasuoka1, Ken Stern2, Yuka Okazaki3, Tetsuya Nishimoto4, Tsutomu Takeuchi1 and Masataka Kuwana1, 1Division of Rheumatology, Department of Internal Medicine, Keio University School of Medicine, Tokyo, Japan, 2Keio University School of Medicine, Tokyo, Japan, 3Rheumatology, Keio University School of Medicine, Tokyo, Japan, 4Department of Medicine, Medical University of South Carolina, Charleston, SC

    Background/Purpose: Systemic sclerosis (SSc) is a systemic fibroproliferative disease characterized by concomitant occurrence of microvascular injury and autoantibody production. It has long been suggested that…
  • Abstract Number: 671 • 2013 ACR/ARHP Annual Meeting

    Autoantibody Diversity In Scleroderma Patients With Antinucleolar Antibodies and Negative For Three Major Disease-Specific Markers

    Sarada Nandiwada1, Troy Jaskowski2, Maureen D. Mayes3, Minoru Satoh4 and Anne E. Tebo1, 1Pathology, University of Utah, Salt Lake City, UT, 2ARUP Laboratories, Salt Lake City, UT, 3University of Texas Health Science Center at Houston, Houston, TX, 4Medicine, University of Florida, Gainesville, FL

    Background/Purpose: Antinuclear antibodies (ANA) in a nucleolar pattern (antinucleolar antibodies, ANoA) by indirect immunofluorescence technique correlate with several autoantibody specificities and clinical manifestations in scleroderma…
  • Abstract Number: 672 • 2013 ACR/ARHP Annual Meeting

    Anti-Th/To Antibodies In Various Systemic Rheumatic Diseases Screened By Anti-Rpp25 ELISA

    Ann D. Chauffe1, Eric S. Sobel2, Michael R. Bubb1, Westley H. Reeves3, Michael Mahler4, Cristina Gascon5, Jason Y.F. Chan1, S. John Calise6, Edward K.L. Chan6 and Minoru Satoh1, 1Medicine, University of Florida, Gainesville, FL, 2Medicine/Div of Rheumatology, University of Florida, Gainesville, FL, 3Rheumatology & Clinical Imm, University of Florida, Gainesville, FL, 4Research, INOVA Diagnostics, San Diego, CA, 5Research, INOVA Diagnostics, Inc., San Diego, CA, 6Oral Biology, University of Florida, Gainesville, FL

    Background/Purpose: Anti-Th/To antibodies (anti-Th) are one of the specificities that show nucleolar staining in indirect immunofluorescence antinuclear antibody test. Anti-Th is associated with systemic sclerosis…
  • Abstract Number: 674 • 2013 ACR/ARHP Annual Meeting

    Systemic Sclerosis Disease Subset Is a Better Predictor Of Long Term Outcome Than Autoantibody Profile

    Svetlana I. Nihtyanova1, Voon H. Ong2 and Christopher P. Denton3, 1Department of Rheumatology, Royal Free and University College Medical School, London, United Kingdom, 2Department of Rheumatology, The Royal Free and University College Medical School, London, United Kingdom, 3Centre for Rheumatology, Royal Free and University College Medical School, London, United Kingdom

    Background/Purpose: Disease subset has been shown to strongly correlate with survival and risk of organ complications in patients with systemic sclerosis (SSc). Nevertheless evidence in…
  • Abstract Number: 675 • 2013 ACR/ARHP Annual Meeting

    Impact Of Male Sex On Survival In Systemic Sclerosis

    Haseena Hussein1, Peter Lee2, Cathy Chau3 and Sindhu R. Johnson4, 1Medicine, Toronto Scleroderma Research Program, Mount Sinai Hospital, Toronto Western Hospital, University of Toronto, Toronto, ON, Canada, 2Lebovic Bldg, Mt. Sinai Hospital, Toronto, ON, Canada, 3Medicine, Toronto Scleroderma Program, Toronto Western Hospital, Mount Sinai Hospital, University of Toronto, Toronto, ON, Canada, 4Medicine, Division of Rheumatology, Toronto Western Hospital, University Health Network Pulmonary Hypertension Programme, Toronto General Hospital, Mount Sinai Hospital and University of Toronto, Toronto, ON, Canada

    Background/Purpose: Systemic sclerosis (SSc) has a female predominance with a female-to-male ratio of 3:1. Sex differences have been seen in many autoimmune diseases; however, little…
  • Abstract Number: 676 • 2013 ACR/ARHP Annual Meeting

    Early Systemic Sclerosis: Marker Autoantibody Positive Patients Have A Faster Pace Of The Disease

    Gabriele Valentini1, Antonella Marcoccia2, Michele Iudici3, Serena Vettori1 and Giovanna Cuomo3, 1Department of Clinical and Experimental Medicine, Rheumatology Unit, Second University of Naples, Naples, Italy, 2Angiology Unit, Sandro Pertini Hospital, Rome, Italy, 3Department of Internal and Experimental Medicine, Second University of Naples, Naples, Italy

    Background/Purpose: To investigate  whether patients affected with any of the 3 subsets of  early systemic sclerosis (SSc)  i.e. Raynaud’s Phenomenon (RP) with  SSc marker autoantibody…
  • « Previous Page
  • 1
  • …
  • 2202
  • 2203
  • 2204
  • 2205
  • 2206
  • …
  • 2425
  • Next Page »
Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology